pharma QA – Page 103

Particulate Matter Oos post-sterile filtration: risk assessment for patient safety and recall

Assessing Particulate Matter OOS After Sterile Filtration: An Investigation for Safety and Compliance In the pharmaceutical industry, maintaining a sterile environment is paramount, especially when producing injectable products. A situation…

Filter Integrity Failure during terminal sterilization: risk assessment for patient safety and recall

Investigating Filter Integrity Failures in Terminal Sterilization: Assessing Risks in Pharmaceutical Manufacturing In the pharmaceutical manufacturing environment, a filter integrity failure during terminal sterilization can pose significant risks to product…

Air Entrapment during shared equipment campaign: cleaning validation and worst-case selection

Addressing Air Entrapment Issues in Shared Equipment Campaigns for Cleaning Validation Air entrapment during shared equipment campaigns can pose significant challenges in pharmaceutical manufacturing, raising compliance concerns during FDA and…

Aseptic Gowning Deviation after maintenance intervention: CAPA package with evidence and effectiveness checks

Aseptic Gowning Deviation Investigation Following Maintenance Activities In the highly regulated environment of pharmaceutical manufacturing, especially when managing parenteral dosage forms, aseptic gowning is a critical process that ensures product…

Filter Integrity Failure post-sterile filtration: CAPA package with evidence and effectiveness checks

Understanding and Addressing Filter Integrity Failure in Sterile Filtration Processes Filter integrity failures in sterile filtration processes are critical issues that can jeopardize the quality and safety of parenteral products.…

Emulsion Inversion at accelerated stability: GMP investigation and CAPA strategy

Understanding Emulsion Inversion at Accelerated Stability: A GMP Investigation Guide Emulsion inversion is a challenge that can arise during the stability testing of topical pharmaceutical forms. This issue has implications…

Media Fill Failure during routine EM trending: data integrity checks for lab and shop floor

Addressing Media Fill Failures Observed in Routine Environmental Monitoring: A Detailed Investigation Guide In the high-stakes environment of pharmaceutical manufacturing, particularly in parenteral dosage forms, the occurrence of media fill…

Media Fill Failure during routine EM trending: risk assessment for patient safety and recall

Risk Assessment and Investigation of Media Fill Failure during Routine EM Trending Media fill failures can be one of the most concerning issues in pharmaceutical manufacturing, particularly for sterile products.…

Phase Separation in cream manufacturing: mixing and sampling controls for QA review

Addressing Phase Separation in Cream Manufacturing: Practical Strategies for Quality Assurance Phase separation in cream manufacturing can significantly impact product quality and stability, leading to unacceptable deviations and potential regulatory…

Ccit Failure during power interruption: how to classify deviation and set disposition

Ccit Failure during Power Outages: Deviation Classification and Disposition Strategies In the realm of pharmaceutical manufacturing, power interruptions can pose serious challenges, especially for parenteral dosage forms requiring stringent storage…

Endotoxin Oos during campaign changeover: FDA/MHRA investigation narrative and batch impact

Investigating Endotoxin OOS Results During Campaign Changeovers in Pharma Manufacturing Endotoxin contamination can significantly disrupt parenteral manufacturing, particularly during campaign changeovers where different products are processed sequentially in the same…

Odor Change after excipient change: GMP investigation and CAPA strategy

GMP Investigation into Odor Change Following Excipient Modification In pharmaceutical manufacturing, the integrity of formulations is paramount, and even minor changes can yield significant sensory impacts. One such issue arises…